Search research articles
Contact Us
Filters
Showing results (171-180 of 271) with videos related to
Page
of 28
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 24, 2017
Biomarker-Based Phase II Trial of Savolitinib in Patients With Advanced Papillary Renal Cell Cancer
Toni K Choueiri, Elizabeth Plimack, Hendrik-Tobias Arkenau, et al.
ESMO Open
|
November 24, 2020
Validation of prognostic scoring systems for patients with metastatic renal cell carcinoma enrolled in phase I clinical trials
Andrew W Hahn, Omar Alhalabi, Pavlos Msaouel, et al.
Nature Medicine
|
August 28, 2021
Author Correction: Inhibition of hypoxia-inducible factor-2α in renal cell carcinoma with belzutifan: a phase 1 trial and biomarker analysis
Toni K Choueiri, Todd M Bauer, Kyriakos P Papadopoulos, et al.
The Lancet. Oncology
|
April 14, 2025
Belzutifan for von Hippel-Lindau disease-associated renal cell carcinoma and other neoplasms (LITESPARK-004): 50 months follow-up from a single-arm, phase 2 study
Ramaprasad Srinivasan, Othon Iliopoulos, Kathryn E Beckermann, et al.
Urologic Oncology
|
February 22, 2015
Clinically nonmetastatic renal cell carcinoma with sarcomatoid dedifferentiation: Natural history and outcomes after surgical resection with curative intent
Megan M Merrill, Christopher G Wood, Nizar M Tannir, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
October 31, 2015
Loss of histone H3 lysine 36 trimethylation is associated with an increased risk of renal cell carcinoma-specific death
Thai H Ho, Payal Kapur, Richard W Joseph, et al.
European Urology
|
August 1, 2025
Epidemiology of Renal Cancer: Incidence, Mortality, Survival, Genetic Predisposition, and Risk Factors
Alessandro Larcher, Riccardo Campi, Axel Bex, et al.
Clinical Genitourinary Cancer
|
February 21, 2017
Outcomes of Patients With Metastatic Renal Cell Carcinoma and Bone Metastases in the Targeted Therapy Era
Sarathi Kalra, Jonathan Verma, Bradley J Atkinson, et al.
Science Translational Medicine
|
October 27, 2021
Replication stress response defects are associated with response to immune checkpoint blockade in nonhypermutated cancers
Daniel J McGrail, Patrick G Pilié, Hui Dai, et al.
Cancers
|
May 5, 2021
Efficacy and Safety of Bevacizumab Plus Erlotinib in Patients with Renal Medullary Carcinoma
Andrew J Wiele, Devaki Shilpa Surasi, Priya Rao, et al.
Page
of 28
Search research articles
Search
Showing results (171-180 of 271) with videos related to
Sort By:
Page
of 28
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 24, 2017
Biomarker-Based Phase II Trial of Savolitinib in Patients With Advanced Papillary Renal Cell Cancer
Toni K Choueiri, Elizabeth Plimack, Hendrik-Tobias Arkenau, et al.
ESMO Open
|
November 24, 2020
Validation of prognostic scoring systems for patients with metastatic renal cell carcinoma enrolled in phase I clinical trials
Andrew W Hahn, Omar Alhalabi, Pavlos Msaouel, et al.
Nature Medicine
|
August 28, 2021
Author Correction: Inhibition of hypoxia-inducible factor-2α in renal cell carcinoma with belzutifan: a phase 1 trial and biomarker analysis
Toni K Choueiri, Todd M Bauer, Kyriakos P Papadopoulos, et al.
The Lancet. Oncology
|
April 14, 2025
Belzutifan for von Hippel-Lindau disease-associated renal cell carcinoma and other neoplasms (LITESPARK-004): 50 months follow-up from a single-arm, phase 2 study
Ramaprasad Srinivasan, Othon Iliopoulos, Kathryn E Beckermann, et al.
Urologic Oncology
|
February 22, 2015
Clinically nonmetastatic renal cell carcinoma with sarcomatoid dedifferentiation: Natural history and outcomes after surgical resection with curative intent
Megan M Merrill, Christopher G Wood, Nizar M Tannir, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
October 31, 2015
Loss of histone H3 lysine 36 trimethylation is associated with an increased risk of renal cell carcinoma-specific death
Thai H Ho, Payal Kapur, Richard W Joseph, et al.
European Urology
|
August 1, 2025
Epidemiology of Renal Cancer: Incidence, Mortality, Survival, Genetic Predisposition, and Risk Factors
Alessandro Larcher, Riccardo Campi, Axel Bex, et al.
Clinical Genitourinary Cancer
|
February 21, 2017
Outcomes of Patients With Metastatic Renal Cell Carcinoma and Bone Metastases in the Targeted Therapy Era
Sarathi Kalra, Jonathan Verma, Bradley J Atkinson, et al.
Science Translational Medicine
|
October 27, 2021
Replication stress response defects are associated with response to immune checkpoint blockade in nonhypermutated cancers
Daniel J McGrail, Patrick G Pilié, Hui Dai, et al.
Cancers
|
May 5, 2021
Efficacy and Safety of Bevacizumab Plus Erlotinib in Patients with Renal Medullary Carcinoma
Andrew J Wiele, Devaki Shilpa Surasi, Priya Rao, et al.
Page
of 28